Microbes Are Active Engineers in Mineral Lifecycles
An open-air, living laboratory is helping researchers improve understanding of how mineral weathering – the breaking down or dissolving of rocks and minerals over time – feeds into Earth's intricate life-support system.
Cooperation Permits Quality of Analytical Examinations in Biomedical Research
The combination of specimen preparation with LMPC and the mature kit technology from Qiagen enables the user to analyze specimens far more specifically and efficiently.
Duke Researchers Uncover Genetic Link to Stroke After Heart Surgery
Patients with a specific combination of polymorphisms in genes responsible for the production of C-reactive protein (CRP) and interleukin-6 (IL-6) suffered stroke at three times higher rate.
Collaboration to Co-Market shRNA Target Validation Technology
RNAx provides Nucleis and its customers with in vitro shRNA validation technology to complement their proprietary transgenic animal generation technology, including the “Speedy Mouse® Technology” and vice versa.
Solexa and Collaborating Scientists Illuminate the Small RNA Component of the Transcriptome
This study generated two million short DNA sequences, known as signature sequences or sequence tags, to identify and quantify both known and novel small RNA molecules.
Applied Biosystems Announces Commercial Availability of TaqMan® MicroRNA Assays
TaqMan® miRNA Assays can be used to differentiate _expression levels of miRNA molecules during embryonic stem cell differentiation.
Agreement to License almaKnowledgeServer (AKS) as Part of Joint Research Project
Researchers based at EMBL headquarters will have access to the system as part of their daily research activities.
Patent Application for Biomarker-based Method to Diagnose Alzheimer's Disease
The patent application is being filed in conjunction with major research institutions in the Houston area, with Power3 having an exclusive license to commercialize the technology involved.
Bayer Selects InforSense for Next Generation Integrative Analytics Infrastructure
InforSense KDE, will provide Bayer with a flexible rapid application development platform to optimize their drug discovery decision-making.
Benitec Patents Upheld In Australia
Benitec Ltd.’s patents have been upheld to focus on developing RNA interference based therapeutics for the treatment of infectious diseases.
Hellsgate Vectors Simplifies the Use of HairpinRNAi
The Hellsgate vectors deliver double stranded hairpin RNA molecules corresponding to each selected gene, thereby destroying the messenger RNA for that gene and preventing its expression, silencing the gene.